New combo shows promise for hard-to-treat liver tumors in colorectal cancer
Disease control
Completed
This study tested a treatment for people with colorectal cancer that spread to the liver and didn't respond to earlier therapies. The approach combines chemotherapy delivered directly to the liver with a targeted drug called fuquintinib. The goal was to shrink liver tumors and co…
Phase: PHASE2 • Sponsor: Meng Qiu • Aim: Disease control
Last updated May 14, 2026 12:05 UTC